Figure 4.
Effects of Buprenorphine Taper Duration on Treatment Retention and Naltrexone Ingestion at the End of Each Study Phase
Data are presented for 1-week, 2-week, and 4-week taper conditions.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.